Studies on the pathogenesis of IFN-α in MG are rare, and one study showed that IFN-α reduces EAMG occurrence by reducing anti-AchR IgG1 and IgG2 b levels as well as lymph node and spleen CD4+T cells (28). Here, CD4 is linked to myasthenia gravis.